Joshua Pinto serves as Executive at Neumora Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Joshua Pinto has executed 7 insider transactions totaling $1.2M, demonstrating a bearish approach to their equity position. Their most recent transaction on Nov 13, 2025 involved selling 2,688 shares valued at $0.
Joshua Pinto currently holds 138,965 shares of Neumora Therapeutics, Inc. (NMRA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Joshua Pinto has been a net seller of NMRA stock. They have purchased $0 and sold $1.2M worth of shares.
Joshua Pinto's most recent insider trade was on Nov 13, 2025, when they sold 2,688 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $11.39 |
| Planned |
| Aug 26, 2024 | NMRA | $372.7K | Sale | 31,642 | $11.78 | Planned |
| Aug 23, 2024 | NMRA | $280.1K | Sale | 24,169 | $11.59 | Planned |
| Aug 22, 2024 | NMRA | $331.4K | Sale | 28,496 | $11.63 | Planned |
| Apr 17, 2024 | NMRA | $0 | Gift | 238,965 | $N/A | Discretionary |
| Feb 14, 2024 | NMRA | $0 | Award | 85,000 | $N/A | Discretionary |